View of Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026

Return to Issue Details Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026 Download Download PDF